The Infectious Disease DxBook provides primary data on clinical infectious disease molecular diagnostics testing for 1,000 labs across the U.S. Data is refreshed annually and includes ~30 infectious disease targets, with detailed information on kits and platforms used, volumes, technologies, and trends, as well as counts of in-use instruments by manufacturer. Historical data since 2016 is also available.
Each year we conduct detailed, expert-led interviews with 1,000 clinical testing laboratories across the U.S. to gather in-depth, primary data on their current testing behaviors. Data collected include:
In addition to the granular, institution-level primary data offered in the Infectious Disease DxBook, DeciBio also offers a model of the infectious disease U.S. hospital market. This model is based on DxBook data and uses extensive secondary research to extrapolate out to the entire U.S. hospital MDx Infectious Disease market. With segmentations by analyte, hospital size, and instrument manufacturer, this model allows a landscape-level view of the market, with implications for both strategic planning and competitive intelligence.
